Product Image

Melatonin 1 mg Raspberry Flavor

Bluebonnet EarthSweet Chewables
4.8
★ ★ ★ ★ ★
(305 ratings)
Melatonin 1 mg
Product Image
Score87
A practical 1 mg chewable with good dose restraint and clear labeling. It targets sleep onset rather than all-night maintenance.
How scoring works
Quantity:120 Tablet(s) • (120 servings)
Goals:
Sleep Support

Score 87

A practical 1 mg chewable with good dose restraint and clear labeling. It targets sleep onset rather than all-night maintenance.
How scoring works
$10.36($0.08 per serving)
Daily Vita
$ 10.36
iHerb
$ 10.36
Walmart
$ 13.89
Vitacost
$ 10.36
Report prices

Analysis

One chewable provides 1 mg melatonin, offering much better dose restraint than common 5 mg or 10 mg products. The focused formula makes it easy to assess personal response.

Immediate-release delivery is most relevant to falling asleep or shifting circadian timing. It may not address frequent overnight waking, and even 1 mg can cause morning effects in sensitive users.

The low dose and simple format make this a practical starting option for many adults. Users can evaluate response without committing to an unnecessarily large serving.

Who is it for
  • Adults new to melatonin
  • Sensitive users seeking a low amount
  • People needing sleep-onset or circadian-timing support
Best for
  • Conservative melatonin use
  • Sleep-onset support
  • A simple chewable starting dose

Pros

  • Provides a modest 1 mg amount
  • One-chewable serving
  • Good dose control
  • Simple and economical formula

Cons

  • No sustained-release feature
  • May still cause drowsiness in sensitive users
  • Small carbohydrate contribution

Warnings

  • The 1 mg melatonin serving may cause morning grogginess, vivid dreams, headache, or impaired alertness
  • Do not combine melatonin with alcohol, sedatives, or other sleep products without professional guidance
  • Do not drive or operate machinery after taking it
  • Pregnant or breastfeeding users should seek medical guidance before using melatonin

Nutrient quality

91 Highest impact

The low melatonin amount closely fits circadian timing without looking aggressive. Chewable delivery is practical, and the focused formula avoids low-value additions.

.

Ingredient transparency

90 Highest impact

The active amount and ingredient name are clear without a proprietary blend. Serving information is straightforward, but a separate excipient list is not supplied.

.

Customer satisfaction

68 High impact

The supplied average rating and rating volume indicate positive but less certain satisfaction. No issue-level feedback was supplied, so repeated complaints or purpose fit cannot be verified.

.

Value for money

96 Highest impact

The serving cost is highly favorable for a low-dose chewable. Minimal additions and a large supply support excellent category competitiveness.

.
Report analysis

Goals

Sleep Support
Impact
Highest effect
A+ Goal FitA Strength of SupportC CoverageA+ Formula Quality
Melatonin · 1 mg

The chewable format provides a conservative dose for sleep onset and circadian timing. It provides a clearly disclosed 1 mg melatonin amount for a defined sleep-related pathway.

The single pathway does not address relaxation or overnight maintenance. The focused dose may suit users who want straightforward circadian support.

Study evidence
Melatonin Supportive 181 studies

Ingredients

IngredientAmount per serving
Total Carbohydrate
1 Gram(s)
Melatonin
1 mg
Gluten Free Adults 18–50 Vegan Kosher Dairy Free Women No Allergies Children 4+ Vegetarian
Report overview
Melatonin · 1 mg OverallScore71
F Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyA+ Value

The low melatonin dose is well aligned with circadian support and may reduce the chance of next-day grogginess. A single chewable provides clear dosing, while the label does not identify sustained-release technology or independent finished-product testing. The large serving supply and low cost per use support strong practical value.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Meta-analysis: melatonin for the treatment of primary sleep disorders.
    Ferracioli-Oda E; Qawasmi A; Bloch MH · PloS one · 2013
    Meta-analysis1,683 participants19 studies pooledSleep Support forMelatonin
  2. Efficacy on sleep parameters and tolerability of melatonin in individuals with sleep or mental disorders: A systematic review and meta-analysis.
    Salanitro M; Wrigley T; Ghabra H; de Haan E; Hill CM; Solmi M; Cortese S · Neuroscience and biobehavioral reviews · 2022
    Meta-analysis1,998 participants34 studies pooledSleep Support forMelatonin
  3. Exogenous melatonin as a treatment for secondary sleep disorders: A systematic review and meta-analysis.
    Li T; Jiang S; Han M; Yang Z; Lv J; Deng C; Reiter RJ; Yang Y · Frontiers in neuroendocrinology · 2019
    Meta-analysis205 participants7 studies pooledSleep Support forMelatonin
  4. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.
    Sletten TL; Magee M; Murray JM; Gordon CJ; Lovato N; Kennaway DJ; Gwini SM; Bartlett DJ; Lockley SW; Lack LC; Grunstein RR; Rajaratnam SMW; Delayed Sleep on Melatonin (DelSoM) Study Group · PLoS medicine · 2019
    Randomized trial116 participantsSleep Support forMelatonin
  5. Melatonin treatment for age-related insomnia.
    Zhdanova IV; Wurtman RJ; Regan MM; Taylor JA; Shi JP; Leclair OU · The Journal of clinical endocrinology and metabolism · 2001
    Randomized trial30 participantsSleep Support forMelatonin
  6. Effects of melatonin on postoperative sleep quality: a systematic review, meta-analysis, and trial sequential analysis.
    Tsukinaga A; Mihara T; Takeshima T; Tomita M; Goto T · Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2023
    Meta-analysis516 participants8 studies pooledSleep Support forMelatonin
  7. Unintended consequences: college students' melatonin usage, sleep disturbance, and depressive symptoms.
    Peltz JS; Rogge R · Sleep and biological rhythms · 2025
    Cohort study331 participantsSleep Support forMelatonin
  8. The Effectiveness of Melatonin for Sleep Disturbances in Parkinson' Disease: Systematic Review and Meta-Analysis.
    Yousef O; Abouelmagd ME; Khaddam H; Shbani A; Yousef R; Meshref M; Hanafi I · Journal of sleep research · 2026
    Meta-analysis409 participants8 studies pooledSleep Support forMelatonin
  9. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N · BMC medicine · 2010
    Randomized trial791 participantsSleep Support forMelatonin
  10. Effects of exogenous melatonin on sleep: a meta-analysis.
    Brzezinski A; Vangel MG; Wurtman RJ; Norrie G; Zhdanova I; Ben-Shushan A; Ford I · Sleep medicine reviews · 2005
    Meta-analysis284 participants8 studies pooledSleep Support forMelatonin